Protein Engineering

Tuesday, January 15, 2013, 8:30am-10:25am EST

Session Co-Chairs:

  • Joel L. Kaar, University of Colorado, Boulder
  • Hadley D. Sikes, Massachusetts Institute of Technology

Invited Speakers:

  • Matt DeLisa, Cornell University- Bottom-up bacterial glycoengineering: from enzymes and pathways to human therapies and vaccines

Oral Presentations:

  • Rudi Fasan, University of Rochester: Fingerprint-Guided Engineering of Selective P450 Catalysts for C—H Functionalization in Complex Molecules
  • Peter Tessier, Rensselaer Polytechnic Institute: Antibodies by Design
  • Marc Ostermeier, Johns Hopkins University: A Protein Therapeutic Modality Founded On Molecular Regulation
  • Kurt Deshayes, Genentech: Altering the Apoptotic Network in Cancer: A Promising Therapeutic Approach

Matthew Peter DeLisa

Matthew DeLisa received his B.S. in Chemical Engineering from the University of Connecticut in 1996; his Ph.D. in Chemical Engineering from the University of Maryland in 2001; and did postdoctoral work at the University of Texas-Austin, Department of Chemical Engineering. DeLisa joined the Department of Chemical and Biomolecular Engineering at Cornell University as an assistant professor in 2003 and was promoted to associate professor in 2009. He recently served as a Gastprofessur at ETH Zürich in the Institut für Mikrobiologie.

Professor DeLisa's research focuses on understanding...

Related Topics: